Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167,901 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries.
Getaneh AM, Li X, Mao Z, Johannesen CK, Barbieri E, van Summeren J, Wang X, Tong S, Baraldi E, Phijffer E, Rizzo C, van Wijhe M, Heikkinen T, Bont L, Willem L, Jit M, Beutels P, Bilcke J; for Respiratory Syncytial Virus Consortium in Europe (RESCEU) investigators. Getaneh AM, et al. Among authors: li x. Vaccine. 2023 Feb 24;41(9):1623-1631. doi: 10.1016/j.vaccine.2023.01.058. Epub 2023 Feb 1. Vaccine. 2023. PMID: 36737318
Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators. Zhang S, et al. J Infect Dis. 2020 Oct 7;222(Suppl 7):S680-S687. doi: 10.1093/infdis/jiz683. J Infect Dis. 2020. PMID: 32227101 Free article.
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial.
Li X, Bilcke J, van der Velden AW, Bongard E, Bruyndonckx R, Sundvall PD, Harbin NJ, Coenen S, Francis N, Bruno P, Garcia-Sangenis A, Glinz D, Kosiek K, Mikó-Pauer R, Radzeviciene Jurgute R, Seifert B, Tsakountakis N, Aabenhus R, Butler CC, Beutels P. Li X, et al. Clin Drug Investig. 2021 Aug;41(8):685-699. doi: 10.1007/s40261-021-01057-y. Epub 2021 Jul 22. Clin Drug Investig. 2021. PMID: 34292510 Free PMC article. Clinical Trial.
Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children.
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. Li X, et al. J Infect Dis. 2022 Aug 12;226(Suppl 1):S95-S101. doi: 10.1093/infdis/jiac064. J Infect Dis. 2022. PMID: 35292816
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.
Li X, Bilcke J, van der Velden AW, Bruyndonckx R, Coenen S, Bongard E, de Paor M, Chlabicz S, Godycki-Cwirko M, Francis N, Aabenhus R, Bucher HC, Colliers A, De Sutter A, Garcia-Sangenis A, Glinz D, Harbin NJ, Kosiek K, Lindbæk M, Lionis C, Llor C, Mikó-Pauer R, Radzeviciene Jurgute R, Seifert B, Sundvall PD, Touboul Lundgren P, Tsakountakis N, Verheij TJ, Goossens H, Butler CC, Beutels P; ALIC4Etrial investigators. Li X, et al. Eur J Health Econ. 2023 Aug;24(6):909-922. doi: 10.1007/s10198-022-01521-2. Epub 2022 Sep 22. Eur J Health Econ. 2023. PMID: 36131214 Free PMC article.
167,901 results
You have reached the last available page of results. Please see the User Guide for more information.